Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome

NCT03152591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: LIK066
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals